Literature DB >> 29432079

First-Line Treatment of Hormone-Sensitive Metastatic Prostate Cancer: Is There a Single Standard of Care?

Che-Kai Tsao1, William K Oh1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29432079     DOI: 10.1200/JCO.2017.77.4315

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  1 in total

1.  miR-31-3p functions as a tumor suppressor by directly targeting GABBR2 in prostate cancer.

Authors:  Sujin Choi; Soonchul Lee; Young-Hoon Han; Junwon Choi; Isaac Kim; Jusung Lee; Hyun-Ju An
Journal:  Front Oncol       Date:  2022-08-18       Impact factor: 5.738

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.